Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polis

Showing results (561-570 of 614) with videos related to

Pageof 62
Sort By:
The Journal of Infectious Diseases|August 5, 2003
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virusJorge A Tavel, Irini Sereti, Robert E Walker, et al.
AIDS (London, England)|June 24, 2003
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimenMichael A Polis, Daniel L Suzman, Christian P Yoder, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Journal of the American Geriatrics Society|April 17, 2004
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trialAlan J Kivitz, Maria W Greenwald, Stanley B Cohen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2018
Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intakeAntonia Serrano, Francisco J Pavon, Matthew W Buczynski, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
The Lancet. Infectious Diseases|September 18, 2022
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trialHeather Platt, Tosin Omole, Jose Cardona, et al.
The Journal of Clinical Investigation|July 2, 2014
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeEric G Meissner, David Wu, Anu Osinusi, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic responseSusanna Naggie, Anu Osinusi, Antonios Katsounas, et al.
Oncotarget|June 30, 2020
Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumorsSophie Favril, Chiara Brioschi, Katrien Vanderperren, et al.
Pageof 62

Showing results (561-570 of 614) with videos related to

Sort By:
Pageof 62
The Journal of Infectious Diseases|August 5, 2003
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virusJorge A Tavel, Irini Sereti, Robert E Walker, et al.
AIDS (London, England)|June 24, 2003
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimenMichael A Polis, Daniel L Suzman, Christian P Yoder, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Journal of the American Geriatrics Society|April 17, 2004
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trialAlan J Kivitz, Maria W Greenwald, Stanley B Cohen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2018
Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intakeAntonia Serrano, Francisco J Pavon, Matthew W Buczynski, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
The Lancet. Infectious Diseases|September 18, 2022
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trialHeather Platt, Tosin Omole, Jose Cardona, et al.
The Journal of Clinical Investigation|July 2, 2014
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcomeEric G Meissner, David Wu, Anu Osinusi, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic responseSusanna Naggie, Anu Osinusi, Antonios Katsounas, et al.
Oncotarget|June 30, 2020
Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumorsSophie Favril, Chiara Brioschi, Katrien Vanderperren, et al.
Pageof 62